Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Flu Vaccine market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Flu Vaccine market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Flu Vaccine market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Flu Vaccine products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Flu Vaccine products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Flu Vaccine market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Flu Vaccine development has been the leading industry trend of Flu Vaccine market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Flu Vaccine Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Whole Virus Vaccines,Split Virus Vaccines,Subunit Vaccines,Live Attenuated Virus Vaccines |
| By Application Outlook |
For Children (6 months to 3 years),For Adults and Children over 3 years, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
CSL,GSK,Sanofi Pasteur,Mylan,AstraZeneca,Pfizer,Johnson & Johnson |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- CSL
- GSK
- Sanofi Pasteur
- Mylan
- AstraZeneca
- Pfizer
- Johnson & Johnson
Flu Vaccine Market, By Type
- Whole Virus Vaccines
- Split Virus Vaccines
- Subunit Vaccines
- Live Attenuated Virus Vaccines
Flu Vaccine Market, By Application
- For Children (6 months to 3 years)
- For Adults and Children over 3 years
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Global Flu Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Flu Vaccine Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Whole Virus Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Split Virus Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Subunit Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.4 Live Attenuated Virus Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Flu Vaccine Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Flu Vaccine Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Flu Vaccine Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Flu Vaccine Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Flu Vaccine Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Flu Vaccine Market Assessment by Type
8.1 Asia Pacific Flu Vaccine Market Assessment by Application (Consumption and Market Share)
8.2 North America Flu Vaccine Market Assessment by Application (Consumption and Market Share)
8.3 Europe Flu Vaccine Market Assessment by Application (Consumption and Market Share)
8.4 South America Flu Vaccine Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Flu Vaccine Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 CSL
9.1.1 CSL Profiles
9.1.2 CSL Product Portfolio
9.1.3 CSL Flu Vaccine Business Performance
9.1.4 CSL Flu Vaccine Business Development and Market Status
9.2 GSK
9.2.1 GSK Profiles
9.2.2 GSK Product Portfolio
9.2.3 GSK Flu Vaccine Business Performance
9.2.4 GSK Flu Vaccine Business Development and Market Status
9.3 Sanofi Pasteur
9.3.1 Sanofi Pasteur Profiles
9.3.2 Sanofi Pasteur Product Portfolio
9.3.3 Sanofi Pasteur Flu Vaccine Business Performance
9.3.4 Sanofi Pasteur Flu Vaccine Business Development and Market Status
9.4 Mylan
9.4.1 Mylan Profiles
9.4.2 Mylan Product Portfolio
9.4.3 Mylan Flu Vaccine Business Performance
9.4.4 Mylan Flu Vaccine Business Development and Market Status
9.5 AstraZeneca
9.5.1 AstraZeneca Profiles
9.5.2 AstraZeneca Product Portfolio
9.5.3 AstraZeneca Flu Vaccine Business Performance
9.5.4 AstraZeneca Flu Vaccine Business Development and Market Status
9.6 Pfizer
9.6.1 Pfizer Profiles
9.6.2 Pfizer Product Portfolio
9.6.3 Pfizer Flu Vaccine Business Performance
9.6.4 Pfizer Flu Vaccine Business Development and Market Status
9.7 Johnson & Johnson
9.7.1 Johnson & Johnson Profiles
9.7.2 Johnson & Johnson Product Portfolio
9.7.3 Johnson & Johnson Flu Vaccine Business Performance
9.7.4 Johnson & Johnson Flu Vaccine Business Development and Market Status
10 World Flu Vaccine Market Assessment by Players
10.1 Global Flu Vaccine Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Flu Vaccine Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Flu Vaccine Price (USD/Unit) of Players 2014-2020
10.4 Global Flu Vaccine Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Flu Vaccine Sales Assessment of Players 2014-2020
11.1.2 North America Flu Vaccine Revenue Assessment of Players 2014-2020
11.1.3 North America Flu Vaccine Price Assessment of Players 2014-2020
11.1.4 North America Flu Vaccine Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Flu Vaccine Sales Assessment of Players 2014-2020
11.2.2 Europe Flu Vaccine Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Flu Vaccine Price Assessment of Players 2014-2020
11.2.4 Europe Flu Vaccine Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Flu Vaccine Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Flu Vaccine Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Flu Vaccine Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Flu Vaccine Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Flu Vaccine Sales Assessment of Players 2014-2020
11.4.2 South America Flu Vaccine Revenue Assessment of Players 2014-2020
11.4.3 South America Flu Vaccine Price Assessment of Players 2014-2020
11.4.4 South America Flu Vaccine Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Flu Vaccine Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Flu Vaccine Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Flu Vaccine Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Flu Vaccine Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Flu Vaccine Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Flu Vaccine Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Flu Vaccine Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Flu Vaccine Sales by Countries/Regions 2014-2020
12.2.2 North America Flu Vaccine Revenue by Countries/Regions 2014-2020
12.2.3 North America Flu Vaccine Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Flu Vaccine Sales by Countries/Regions 2014-2020
12.3.2 Europe Flu Vaccine Revenue by Countries/Regions 2014-2020
12.3.3 Europe Flu Vaccine Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Flu Vaccine Sales by Countries/Regions 2014-2020
12.4.2 South America Flu Vaccine Revenue by Countries/Regions 2014-2020
12.4.3 South America Flu Vaccine Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Flu Vaccine Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Flu Vaccine Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Flu Vaccine Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Flu Vaccine Sales & Revenue Forecast 2020-2026
14.1 World Flu Vaccine Sales and Revenue Forecast by Regions 2020-2026
14.1.1 World Flu VaccineSales and Market Share by Regions
14.1.2 World Flu VaccineRevenue and Market Share by Regions
15 Asia Flu Vaccine Market Forecast 2020-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2020-2026
15.1.1 Whole Virus Vaccines
15.1.2 Split Virus Vaccines
15.1.3 Subunit Vaccines
15.1.4 Live Attenuated Virus Vaccines
15.2 Consumption Forecast by Application, 2020-2026
16 North America Flu Vaccine Market Forecast 2020-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2020-2026
16.1.1 Whole Virus Vaccines
16.1.2 Split Virus Vaccines
16.1.3 Subunit Vaccines
16.1.4 Live Attenuated Virus Vaccines
16.2 Consumption Forecast by Application, 2020-2026
17 Europe Flu Vaccine Market Forecast 2020-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2020-2026
17.1.1 Whole Virus Vaccines
17.1.2 Split Virus Vaccines
17.1.3 Subunit Vaccines
17.1.4 Live Attenuated Virus Vaccines
17.2 Consumption Forecast by Application, 2020-2026
18 South America Flu Vaccine Market Forecast 2020-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2020-2026
18.1.1 Whole Virus Vaccines
18.1.2 Split Virus Vaccines
18.1.3 Subunit Vaccines
18.1.4 Live Attenuated Virus Vaccines
18.2 Consumption Forecast by Application, 2020-2026
19 Middle East and Africa Flu Vaccine Market Forecast 2020-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2020-2026
19.1.1 Whole Virus Vaccines
19.1.2 Split Virus Vaccines
19.1.3 Subunit Vaccines
19.1.4 Live Attenuated Virus Vaccines
19.2 Consumption Forecast by Application, 2020-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Flu Vaccine Price (USD/Unit) Trend 2020-2026
20.2 Global Flu Vaccine Gross Profit Trend 2020-2026
21 Conclusion
